Hepatology

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Hepacivirus 65%
3. Fibrosis 37%
4. End Stage Liver Disease 28%
5. Hepatitis C 28%
6. Liver 23%
7. Tissue Donors 22%
8. Ribavirin 21%
9. Transplants 20%
10. Transplant Recipients 18%
11. Genotype 14%
12. Virus Diseases 14%
13. Transplantation 14%
14. Acute-On-Chronic Liver Failure 12%
15. Blood Cells 11%
16. Recurrence 11%
17. Liver Diseases 11%
18. Chronic Hepatitis C 10%
19. Infections 10%
20. Hepatocellular Carcinoma 9%
21. Serum 9%
22. Therapeutics 9%
23. Interferons 9%
24. GB virus C 9%
25. Sustained Virologic Response 8%
26. Survival 8%
27. RNA 8%
28. Allografts 8%
29. Virus Replication 8%
30. Living Donors 8%
31. Antiviral Agents 7%
32. Simeprevir 7%
33. Hepatitis 7%
34. Hepatic Encephalopathy 7%
35. Sofosbuvir 7%
36. Multicenter Studies 7%
37. Quasispecies 6%
38. Graft Survival 6%
39. Inpatients 6%
40. Hepatitis B 6%
41. Acute Kidney Injury 6%
42. Mortality 6%
43. sofosbuvir drug combination ledipasvir 5%
44. Gastroenterology 5%
45. Hepatopulmonary Syndrome 5%
46. Hepatitis B virus 5%
47. Placebos 5%
48. Immunosuppression 5%
49. Portal Hypertension 5%